Organon¡¯s spinoff from MDS to be completed in June
By Eo, Yun-Ho | translator Alice Kang
21.05.23 12:04:18
°¡³ª´Ù¶ó
0
Spinoff to be completed at headquarters by next month¡¦ procedures such as transfer of licenses etc. remain in Korea
Moved into the Gwanghwamun office last year¡¦ will focus on women¡¯s health and biosimilars
Industry sources expect the administrative spin-off at the global headquarters of MSD and Organon to be completed within the next month (June). Following the spinoff, Organon & Co. will launch as a completely independent corporation in Korea as well.
Organon¡¯s Korean subsidiary has already moved into the shared office 'WeWork Gwanghwamun¡¯ located in The K Twin Tower in Junghak-dong, Jongno-gu, Seoul last year, and has undergone the necessary processes for its separation.
However, the legal procedures of the spinoff may take a while. Organon is currently undergoing procedures to change the license holder for its products,
Eo, Yun-Ho(unkindfish@dailypharm.com)
If you want to see the full article, please JOIN US (click)